.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Chinese Patent Office
Cerilliant
McKesson
Covington
Boehringer Ingelheim
Citi
Cantor Fitzgerald
Accenture

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072575

« Back to Dashboard

NDA 072575 describes PRAZOSIN HYDROCHLORIDE, which is a drug marketed by Am Therap, Dava Pharms Inc, Idt Australia Ltd, Mylan, Purepac Pharm, Teva Pharms, and Watson Labs, and is included in fifteen NDAs. It is available from eleven suppliers. Additional details are available on the PRAZOSIN HYDROCHLORIDE profile page.

The generic ingredient in PRAZOSIN HYDROCHLORIDE is prazosin hydrochloride. There are sixteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the prazosin hydrochloride profile page.

Summary for 072575

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Cardiovascular Agents
Genitourinary Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 072575

Mechanism of ActionAdrenergic alpha-Antagonists

Medical Subject Heading (MeSH) Categories for 072575

Suppliers and Packaging for NDA: 072575

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PRAZOSIN HYDROCHLORIDE prazosin hydrochloride CAPSULE;ORAL 072575 ANDA Mylan Pharmaceuticals Inc. 0378-1101 0378-1101-01 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1101-01)
PRAZOSIN HYDROCHLORIDE prazosin hydrochloride CAPSULE;ORAL 072575 ANDA Mylan Pharmaceuticals Inc. 0378-1101 0378-1101-10 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-1101-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 5MG BASE
Approval Date:May 16, 1989TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 2MG BASE
Approval Date:May 16, 1989TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 1MG BASE
Approval Date:May 16, 1989TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Julphar
Cantor Fitzgerald
Cipla
Mallinckrodt
Accenture
Chubb
Healthtrust
Novartis
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot